Epigenetic regulation of decidual inflammation
Epigenetic regulation of decidual inflammation
批准号:
9067208
负责人:
Adrian Erlebacher
金额:
$47.55万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-01 至 2018-05-31
关键词:
AddressAffectAnimal ModelArchivesBiochemicalBiological AssayCXCL12 geneCandidate Disease GeneCell Differentiation processCellsCharacteristicsConfocal MicroscopyDNADataDeciduaDevelopmentDiscipline of obstetricsEctopic ExpressionEndometrial Stromal CellEpigenetic ProcessEvaluationFetusFirst Pregnancy TrimesterFluorescent in Situ HybridizationFoundationsGene ExpressionGene SilencingGene TargetingGene TransferGenesGoalsGrowthHealthHistonesHumanImmunofluorescence ImmunologicImmunologyImpairmentIn SituInduced AbortionInflammationInflammatoryInflammatory ResponseLaboratoriesLeukocyte TraffickingLeukocytesLinkMacrophage Colony-Stimulating FactorMediatingMethodologyMethodsMolecularMusParaffin EmbeddingPathogenesisPathologyPathway interactionsPhenotypePhysiologicalPlacentaPlayPregnancyPregnancy ComplicationsPremature BirthPropertyProtocols documentationRegulationReproductive ImmunologyRoleSpecimenStaining methodStainsStromal Cell-Derived Factor 1Stromal CellsSubfamily lentivirinaeT-LymphocyteTechniquesTissuesUterusWorkbasechemokinecytokinedensityepigenetic regulationhistone modificationinsightmacrophagenovelpregnantpreventprogramspromoterresearch studyresponse
中文摘要
描述(由申请人提供):由于我们目前缺乏对潜在致病机制的了解,预防早产和人类妊娠其他并发症的策略的开发受到了极大的阻碍。特别是,对蜕膜的内在炎症特征知之甚少,蜕膜是围绕胎儿和胎盘的特化子宫间质组织。这个建议是基于我的实验室最近的工作,在控制蜕膜炎症和白细胞运输在怀孕的小鼠子宫的分子途径。我们已经发现,子宫内膜基质细胞(ESC)分化为蜕膜基质细胞(DSC)需要通过其启动子积累的H3 K27 me 3抑制性组蛋白标记的选择炎性趋化因子基因的表观遗传沉默。这种新的发育程序大大降低了蜕膜表现炎症反应和积累活化T细胞的潜力。在未发表的数据中,我们发现DSC分化还需要编码多功能趋化因子CXCL 12的Cxcl 12和编码巨噬细胞生长因子CSF-1的Csf 1的沉默。总之,这些发现提出了一个类似的“蜕膜基因沉默”程序是否在人类DSC中活跃的问题,并表明该程序的失调可能是各种胎盘/蜕膜病理学的基础。该提案分为三个具体目标。目的我试图获得更深入的了解蜕膜基因沉默的广度,分子特征和功能意义,再次使用小鼠作为模式生物。这些实验将为评估人类妊娠中蜕膜基因沉默以及考虑其与人类妊娠并发症的潜在意义奠定基础。目的二,这构成了大部分的建议,采用新鲜的前三个月蜕膜标本和一些生化技术,以确定是否蜕膜基因沉默是人类妊娠的一个特点。目的III开发一种新的组蛋白标记免疫染色/DNA荧光原位杂交(DNA-FISH)方法,用于在单细胞水平检测蜕膜基因沉默程序,以便最终检测该程序的潜在失调。
存档的胎盘/蜕膜病理标本。
英文摘要
DESCRIPTION (provided by applicant): The development of strategies to prevent preterm birth and other complications of human pregnancy has been greatly hindered by our current lack of understanding of underlying pathogenic mechanisms. In particular, little is known about the intrinsic inflammatory characteristics of the decidua, the specialized uterine stromal tissue that surrounds the fetus and placenta. This proposal is based upon recent work from my laboratory on the molecular pathways that control decidual inflammation and leukocyte trafficking in the pregnant mouse uterus. We have found that the differentiation of endometrial stromal cells (ESCs) into decidual stromal cells (DSCs) entails the epigenetic silencing of select inflammatory chemokine genes through their promoter accrual of the H3K27me3 repressive histone mark. This novel developmental program dramatically reduces the potential of the decidua to manifest an inflammatory response and accumulate activated T cells. In unpublished data, we have found that DSC differentiation also entails the silencing of Cxcl12 encoding the multifunctional chemokine CXCL12, and Csf1 encoding the macrophage growth factor CSF-1. Together, these findings raise the question of whether an analogous "decidual gene silencing" program is active in human DSCs, and suggest that dysregulation of this program may underlie a variety of placental/decidual pathologies. The proposal is divided into three Specific Aims. Aim I seeks to gain greater insight into the breadth, molecular characteristics, and functional significance of decidual gene silencing, again using mice as a model organism. These experiments will establish a foundation for evaluating decidual gene silencing in human pregnancy, and for considering its potential significance with regards to human pregnancy complications. Aim II, which constitutes the bulk of the proposal, employs fresh first trimester decidual specimens and a number of biochemical techniques to determine whether decidual gene silencing is a feature of human pregnancy. Aim III develops a novel histone mark immunostaining/DNA fluorescence in situ hybridization (DNA-FISH) protocol for detecting the decidual gene silencing program at the single cell level so that potential dysregulation of this program can ultimately be detected in
archived placental/decidual pathological specimens.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1387/ijdb.140054ae
发表时间:
2014
期刊:
The International journal of developmental biology
影响因子:
--
作者:
[Nancy P, Erlebacher A]
通讯作者:
Erlebacher A
Immunological, epigenetic and developmental determinants of early pregnancy success
-
批准号:10673393
-
项目类别:
-
资助金额:$165.0万
-
财政年份:2023
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetics of decidual inflammation
-
批准号:10673396
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2023
-
负责人:Adrian Erlebacher
-
依托单位:
Administrative Core
-
批准号:10673394
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2023
-
负责人:Adrian Erlebacher
-
依托单位:
The IL-33/ILC2 axis in parturition
-
批准号:10318956
-
项目类别:
-
资助金额:$64.06万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
Predoctrol Training in Biomedical Sciences
-
批准号:10669046
-
项目类别:
-
资助金额:$61.69万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
Predoctrol Training in Biomedical Sciences
-
批准号:10440361
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
The IL-33/ILC2 axis in parturition
-
批准号:10543446
-
项目类别:
-
资助金额:$64.06万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
The IL-33/ILC2 axis in parturition
-
批准号:9916253
-
项目类别:
-
资助金额:$63.86万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
The IL-33/ILC2 axis in parturition
-
批准号:10083186
-
项目类别:
-
资助金额:$64.06万
-
财政年份:2020
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetics of uterine quiescence
-
批准号:10512053
-
项目类别:
-
资助金额:$62.18万
-
财政年份:2018
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetics of uterine quiescence
-
批准号:10293599
-
项目类别:
-
资助金额:$62.18万
-
财政年份:2018
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetics of uterine quiescence
-
批准号:10054981
-
项目类别:
-
资助金额:$62.18万
-
财政年份:2018
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetic regulation of decidual inflammation
-
批准号:8557829
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Inflammation and immunity in the crucible of premalignancy
-
批准号:9270511
-
项目类别:
-
资助金额:$45.53万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Inflammation and immunity in the crucible of premalignancy
-
批准号:9031731
-
项目类别:
-
资助金额:$45.53万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Inflammation and immunity in the crucible of premalignancy
-
批准号:8635317
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Inflammation and immunity in the crucible of premalignancy
-
批准号:8504160
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Inflammation and immunity in the crucible of premalignancy
-
批准号:8827711
-
项目类别:
-
资助金额:$48.69万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Epigenetic regulation of decidual inflammation
-
批准号:8666722
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2013
-
负责人:Adrian Erlebacher
-
依托单位:
Dendritic cell behavior at the maternal/fetal interface
-
批准号:7328593
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2005
-
负责人:Adrian Erlebacher
-
依托单位:
海外基金